A new device to improve inhaled drug delivery for pulmonary hypertension
Official title: Novel Device to Optimize Aerosol Drug Delivery for Pulmonary Hypertension Treatment
Funded at Bridgesource Medical Corporation · NIH-10912642 · Data updated 2026-11-12
This study is testing a new nebulizer that changes how it delivers medicine based on how you breathe, making it easier for people with pulmonary hypertension, especially older adults, to get their treatments and feel better.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Bridgesource Medical Corporation NIH-funded |
| Lab location | 1 site (Austin, United States) |
| Project start | August 1, 2020 |
| Project end | August 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $875,246 |
| NIH project number | 5R44HL154960-03 |
| Project ID | NIH-10912642 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are patients with pulmonary hypertension, particularly elderly individuals who struggle with traditional inhalation therapies.
✕Less likely to help
Patients with mild respiratory conditions or those who do not require aerosolized medication may not benefit from this research.
What this research studies
This research focuses on developing a breath-adaptive nebulizer that can deliver aerosolized medications more effectively for patients with pulmonary hypertension. The device will adjust the size of aerosol droplets and the timing of drug delivery based on the patient's breathing patterns, making it easier for patients, especially the elderly, to receive their medications. By improving the efficiency of drug delivery, this device aims to enhance treatment compliance and outcomes for individuals with respiratory conditions. The ultimate goal is to create a device that can be approved by the FDA for clinical use.
Why it matters
Potential benefit: If successful, this research could lead to a more effective and user-friendly method of delivering medications for patients with pulmonary hypertension.
How similar studies have gone: Other research has shown promise in improving aerosol delivery systems, but this specific approach with a breath-adaptive nebulizer is relatively novel.
Where this research is happening
-
Bridgesource Medical Corporation
Austin, United States Active
Researchers
- Principal investigator: Porterfield, John E — Bridgesource Medical Corporation
- Study coordinator: Porterfield, John E
Related research
Other NIH-funded projects on the same topics.
-
Understanding how CD4 T cells fuel schistosomiasis-related lung disease
A study explores how specific immune cells and inflammatory signals in schistosomiasis may contribute to pulmonary hypertension in people affected by the disease.
-
CD4 T Cells, Schistosoma, and Pulmonary Hypertension: Understanding How Immune Cells Drive Disease
A human-health focused study uses a mouse model and human samples to explore how immune cells and inflammation may contribute to a lung blood vessel disease linked to schistosomiasis.
-
CD4 T Cells and Schistosoma-Related Pulmonary Hypertension
A study to understand how specific immune cells behave in a lung complication caused by schistosomiasis, with the goal of finding targets to prevent or treat it.
-
Clinical CT Imaging to identify and subtype pulmonary hypertension in COPD
A new CT imaging approach aims to help doctors detect and classify pulmonary hypertension in people with COPD.
-
Right heart remodeling in pulmonary hypertension
In people with pulmonary hypertension, researchers are studying how the right side of the heart changes and why it fails, with the goal of finding new treatments.
-
TEMPO-PH: How the right heart adapts in pulmonary hypertension over time
A study to build a detailed molecular portrait of why the right side of the heart fails in pulmonary hypertension and how a common heart medicine might help.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.